Report Content
Chapter 1 Methodology & Scope
1.1 Market definitions
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Data Sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid Sources
1.4.2.2 Public Sources
Chapter 2 Executive Summary
2.1 U.S. minoxidil industry 3600 synopsis, 2016 - 2027
2.1.1 Business Trends
2.1.2 Product trends
2.1.3 Distribution channel trends
Chapter 3 US Minoxidil Industry Insights
3.1 Industry segmentation
3.2 Impact of COVID-19 on global economy
3.3 Industry ecosystem analysis
3.3.1 Raw materials
3.3.2 Manufacturers
3.3.3 Distributors
3.3.4 Distribution channel analysis
3.3.5 Profit margin trend
3.3.6 Vendor matrix
3.3.7 COVID-19 impact on value chain
3.4 Regulatory landscape
3.4.1 U.S.
3.4.1.1 Department of Health and Human Services (NDA 021812/S-009)
3.5 Raw material analysis
3.5.1 Impact of COVID-19 on raw material supply
3.6 Technology Landscape
3.6.1 Potential application scenario
3.6.1.1 Minoxidil for beard growth
3.6.1.2 Alternative minoxidil formulations
3.6.2 Formulation Process
3.6.3 Solid lipid nanoparticles
3.6.4 Propylene glycol minoxidil topical formulation for hair loss
3.7 Global alopecia industry scenario
3.7.1 Minoxidil vs other hair loss treatments
3.7.1.1 Dermatology Uses of Minoxidil
3.7.1.1.1 Androgenetic Alopecia (AGA)
3.7.1.1.2 Hair Transplant
3.7.1.1.3 Alopecia Areata
3.7.1.2 Minoxidil Side Effects
3.7.1.3 Other Hair Loss Treatments
3.7.1.3.1 Androgen-dependent medications
3.7.1.4 New users % in U.S. for 2017, 2018, 2019, and 2020
3.7.1.4.1 Demographic trends
3.7.1.4.2 Consumer buying behaviour
3.7.1.4.2.1 Unmet needs
3.7.1.4.2.2 Social & Cultural impact forces
3.7.1.4.2.3 Information search
3.7.1.4.2.4 Evaluation of alternative
3.7.1.4.2.5 Purchase decision
3.7.1.4.2.6 Post purchase evaluation
3.7.2 Impact of COVID-19 on consumer buying behavior
3.8 Industry best practices and key buying criteria
3.9 Industry impact forces
3.9.1 Growth drivers
3.9.1.1 Growing consumer spending on hair care products accompanied by expanding distribution channel
3.9.1.2 Developing personal care market along with the increasing prevalence of alopecia areata
3.9.2 Industry pitfalls & challenges
3.9.2.1 Stringent regulations along with possible side effects of minoxidil
3.10 Pricing analysis, 2016 -2027
3.10.1 Impact of COVID-19 on regional pricing
3.11 Cost structure analysis, 2020
3.12 Growth potential analysis, 2020
3.12.1 Emerging business models
3.12.1.1 Merger & Acquisition
3.12.1.2 Capacity expansion
3.12.1.1 Expansion of distribution network
3.13 Porter’s analysis
3.13.1 Threat of new entrants
3.13.2 Supplier power
3.13.3 Buyer power
3.13.4 Threat of substitutes
3.14 Competitive landscape, 2020
3.14.1 Company market share analysis, 2020
3.14.2 Top players overview
3.14.3 Strategy Dashboard
3.15 PESTLE analysis
3.16 COVID-19 impact on U.S. cosmetics industry
Chapter 4 US Minoxidil Market, By Product
4.1 Key product trends
4.2 5% minoxidil
4.2.1 U.S. minoxidil market estimates and forecast from 5% minoxidil, 2016 - 2027, (Thousand Units) (USD Million)
4.3 2% minoxidil
4.3.1 U.S. minoxidil market estimates and forecast from 2% minoxidil, 2016 - 2027, (Thousand Units) (USD Million)
Chapter 5 US Minoxidil Market, By Distribution Channel
5.1 Key distribution channel trends
5.2 Hospital pharmacies
5.2.1 U.S. minoxidil market estimates and forecast from hospital pharmacies, 2016 - 2027, (Thousand Units) (USD Million)
5.3 Retail pharmacies
5.3.1 U.S. minoxidil market estimates and forecast from retail pharmacies, 2016 - 2027, (Thousand Units) (USD Million)
5.4 Online pharmacies
5.4.1 U.S. minoxidil market estimates and forecast from online pharmacies, 2016 - 2027, (Thousand Units) (USD Million)
Chapter 6 Company Profiles
6.1 Kumar Organic Products Limited
6.1.1 Business Overview
6.1.2 Financial Data
6.1.3 Product Landscape
6.1.4 Strategic Outlook
6.1.5 SWOT Analysis
6.2 Par Pharmaceuticals
6.2.1 Business Overview
6.2.2 Financial Data
6.2.3 Product Landscape
6.2.4 SWOT Analysis
6.3 Metapharmaceutical Ind. S.L.
6.3.1 Business Overview
6.3.2 Financial Data
6.3.3 Product Landscape
6.3.4 SWOT Analysis
6.4 Johnson & Johnson Consumer Inc
6.4.1 Business Overview
6.4.2 Financial Data
6.4.3 Product Landscape
6.4.4 SWOT Analysis
6.5 FLAMMA GROUP
6.5.1 Business Overview
6.5.2 Financial Data
6.5.3 Product Landscape
6.5.4 SWOT Analysis
6.6 LGM Pharma
6.6.1 Business Overview
6.6.2 Financial Data
6.6.3 Product Landscape
6.6.4 Strategic Outlook
6.6.5 Swot Analysis
6.7 Perrigo Company PLC
6.7.1 Business Overview
6.7.2 Financial Data
6.7.3 Product Landscape
6.7.4 SWOT Analysis
6.8 Renata Limited
6.8.1 Business Overview
6.8.2 Financial Data
6.8.3 Product Landscape
6.8.4 Strategic outlook
6.8.5 SWOT Analysis
6.9 Costco Wholesale Corporation
6.9.1 Business Overview
6.9.2 Financial Data
6.9.3 Product Landscape
6.9.4 SWOT Analysis
6.10 Walmart
6.10.1 Business Overview
6.10.2 Financial Data
6.10.3 Product Landscape
6.10.4 SWOT Analysis
6.11 Nanz Med Science Pharma Private Limited
6.11.1 Business Overview
6.11.2 Financial Data
6.11.3 Product Landscape
6.11.4 SWOT Analysis
